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Background
Some epidemiological studies report many comorbidities
in migraine, mostly identified through questionnaires and
based on self-reported diagnosis [1]. Pharmacoepidemiolo-
gical studies have also identified some comorbidities. We
evaluated the migraine comorbidities using and comparing
data derived by different methods of study, with the aim of
minimizing the variability of results.
Materials and methods
We evaluated prospectively the prevalence of some
comorbidities in the first 1,000 migraine patients (aged
15-65 years), classified according to the IHS diagnostic
criteria, presenting to the Headache Center (HC) in the
period 2011 to 2013 and resident in the district of the
Empoli Health Authority (HA11). In addition to a
detailed semistructured face to face interview, health
information was researched in the database of specialist
visits, hospitalization or the Emergency Department. Drug
prescription rates of the HA11 pharmaceutical database
(PD) of 155,829 residents aged 15-65 years were also
analyzed, as were the subgroup of 1,108 triptan users.
To increase the strength of the study, the data was
compared to a large database of Health Search (HS) of
the Research Institute of the Italian Society of General
Practice, to which general practitioners contributed with
shared modalities for the regular and complete recording
of the principal health data [2].
Results
In our clinical survey (780 females, 220 males; mean
age 39.5 years; 866 episodic migraine, 134 chronic
migraine) the prevalence of treated diseases were:
depression 5.6%, hypertension, 9.3%, diabetes 1.2%,
asthma 3.3%, hypotiroidism 6.4%, hypertiroidism 0.3%,
hypercholesterolemia 0.5%. These percentages are not
superior to drug prescription rate found in the PD in
the general population. A higher prescription rate for
some chronic diseases was found in triptan users in
comparison with the general population and migraine
patients (HC), but this may be due to drugs also used
in migraine prevention.
The HS database, covering 893,870 subjects aged
14-85 years, showed an increased percentage of depression
(20.0 vs 5.5) and hypotiroidism (6.1 vs 3.7) in migraine
patients, but not of hypertension or diabetes [2].
Conclusions
This was the first study on migraine comorbidities utiliz-
ing three different accurate databases (HC, PD, HS),
within the same country. Our study does not confirm that
many of the comorbidities reported are associated with
migraine, in particular those involved in cardiovascular
risk. The contrasting evidence in the literature could be
due to the bias intrinsic in the method of study: group, age
not comparable, sex differences, marker drugs used off
label, and uncertainness of diagnosis.
Written informed consent to publication was obtained
from the patient(s).
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